OPKO Health OPK
$ 1.56
-0.96%
Quarterly report 2024-Q3
added 11-07-2024
Country |
USA |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Phillip Frost |
Employees in the company |
6 096 |
Shares |
752 M |
Market Cap[1] |
$ 1.17 B |
EBITDA (LTM) |
$ -83 M |
P/E (LTM) |
-7.3 |
P/S (LTM) |
1.55 |
EPS (LTM) |
-0.2 |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.